I sent Scott a couple of emails -- This one on
Post# of 148278
This one on Feb 12 --
The vast majority of shareholders are totally surprised that we have had no news this week despite management saying that we might have gotten news even last week. Have you decided not to release the unblinded data? Has the topline report not been finalized? Are you waiting for the FDA to make a decision?
Any feedback would be appreciated. Perhaps you should do a brief Proactive interview today to tell shareholders where things stand.
And this one yesterday --
Has the data been unblinded? Sent to the FDA? Are things at such a sensitive stage that you can't say anything? Nearly 100% of shareholders would like an update on the current state of affairs.
But no response.